EMR Stock Overview
Emergent Metals Corp. engages in the acquisition and exploration of mineral properties in Canada and the United States.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Emergent Metals Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.065 |
52 Week High | CA$0.17 |
52 Week Low | CA$0.045 |
Beta | 0.58 |
1 Month Change | 30.00% |
3 Month Change | -23.53% |
1 Year Change | -61.76% |
3 Year Change | -90.00% |
5 Year Change | -96.49% |
Change since IPO | -99.98% |
Recent News & Updates
Recent updates
Shareholder Returns
EMR | CA Metals and Mining | CA Market | |
---|---|---|---|
7D | -13.3% | 0.06% | 0.7% |
1Y | -61.8% | -4.6% | 4.9% |
Return vs Industry: EMR underperformed the Canadian Metals and Mining industry which returned -6.2% over the past year.
Return vs Market: EMR underperformed the Canadian Market which returned 5.5% over the past year.
Price Volatility
EMR volatility | |
---|---|
EMR Average Weekly Movement | 30.5% |
Metals and Mining Industry Average Movement | 11.3% |
Market Average Movement | 9.0% |
10% most volatile stocks in CA Market | 18.1% |
10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: EMR's share price has been volatile over the past 3 months.
Volatility Over Time: EMR's weekly volatility has increased from 25% to 30% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1989 | n/a | Dave Watkinson | emergentmetals.com |
Emergent Metals Corp. engages in the acquisition and exploration of mineral properties in Canada and the United States. The company explores for gold, silver, molybdenum, copper, and other mineral deposits. The company holds interest in the Golden Arrow, the New York Canyon, the Mindora, Buckskin Rawhide East, Buckskin Rawhide West, and Koegel Rawhide properties located in Nevada, the United States.
Emergent Metals Corp. Fundamentals Summary
EMR fundamental statistics | |
---|---|
Market cap | CA$2.09m |
Earnings (TTM) | -CA$413.06k |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-5.1x
P/E RatioIs EMR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
EMR income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$302.32k |
Earnings | -US$302.32k |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0094 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0% |
How did EMR perform over the long term?
See historical performance and comparison